Nephrotoxicity of Anti-Angiogenic Therapies.

Van Wynsberghe, Margaux; Flejeo, Joanne; Sakhi, Hamza; Ollero, Mario; Sahali, Dil; Izzedine, Hassan; Henique, Carole

Van Wynsberghe, Margaux; Flejeo, Joanne; Sakhi, Hamza; Ollero, Mario; Sahali, Dil; Izzedine, Hassan; Henique, Carole.

Afiliação

Van Wynsberghe M; INSERM, Institut Mondor de Recherche Biomédicale, Paris Est Creteil University, F-94010 Creteil, France.
Flejeo J; INSERM, Institut Mondor de Recherche Biomédicale, Paris Est Creteil University, F-94010 Creteil, France.
Sakhi H; Service de Néphrologie, CHU Pontchaillou, F-35000 Rennes, France.
Ollero M; INSERM, Institut Mondor de Recherche Biomédicale, Paris Est Creteil University, F-94010 Creteil, France.
Sahali D; INSERM, Institut Mondor de Recherche Biomédicale, Paris Est Creteil University, F-94010 Creteil, France.
Izzedine H; INSERM, Institut Mondor de Recherche Biomédicale, Paris Est Creteil University, F-94010 Creteil, France.
Henique C; Service de Néphrologie, AP-HP, Groupe Henri-Mondor Albert-Chenevier, F-94010 Creteil, France.

Diagnostics (Basel) ; 11(4)2021 Apr 01.

Article em En | MEDLINE | ID: mdl-33916159

Palavras-chave

VEGF signaling; kidney; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google